• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Doctor On Demand Becomes First Telehealth Provider to Support 33M Medicare Part B Beneficiaries

Share:

May 20, 2020

Doctor On Demand, a San Francisco, CA-based virtual care provider, announced it is the first nationwide, full-service telehealth provider to expand its medical services to include Medicare Part B coverage following the Centers for Medicare & Medicaid Services (CMS) expansion of telehealth services in response to the COVID-19 outbreak. The Medicare Part B population consists largely of Americans over the age of 65, many of whom are considered at heightened risk during the pandemic.

Why It Matters

This groundbreaking expansion makes its telehealth services available to 33 million Medicare Part B beneficiaries improving access to high-quality, convenient healthcare for beneficiaries across all 50 states. Through Doctor On Demand, beneficiaries are able to easily connect with a board-certified physician of their choice over secure live video from home, 24 hours a day, 7 days a week.

Beneficiaries can access consistent medical care for 90 percent of the most common conditions treated by both primary care and urgent care facilities, including diagnosis and testing of COVID-19; typical ailments like infections, rashes, cold and flu; ongoing care of chronic disease like asthma and COPD, diabetes, high blood pressure, high cholesterol and thyroid issues; and for prescription refills. Patients can see the same physician time and time again, building a trusted, personal relationship via video. Prior to CMS’s expansion of telemedicine to those with Medicare Part B coverage, Doctor On Demand had already seen rapid adoption of its virtual care services within this demographic, with patient registrations for the 65 and over age group growing by nearly 150 percent in March.

“We’re proud to bring high-quality, compassionate care to Medicare beneficiaries who are especially vulnerable at this time,” said Hill Ferguson, CEO of Doctor On Demand. “We mobilized quickly to care for this population following the CMS update, and are uniquely positioned to scale quickly to meet anticipated demand.”

Waiving Copays During COVID-19

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Doctor On Demand can be accessed through a smartphone, tablet or computer by downloading the Doctor On Demand app from the App Store or Google Play, or from a web browser. To register, beneficiaries enter a valid email address, Medicare ID number, and a phone number. During the COVID-19 public health emergency, Doctor On Demand is waiving the copay for Medicare Part B beneficiaries, as permitted by government policy.

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • AI for Pharma and Biotech Market 2022 Extent USD 4200% Billion By 2027 | Expected to Grow at a Compound Annual Growth Rate of 30.51% | No of Page 124AI for Pharma and Biotech Market 2022 Extent USD 4200% Billion By 2027 | Expected to Grow at a Compound Annual Growth Rate of 30.51% | No of Page 124
  • KRY Announces Merger with Swedish Healthcare Company HelsaKRY Announces Merger with Swedish Healthcare Company Helsa
  • PE Firm Acquires Intelligent Medical Objects (IMO) for $1.5B+PE Firm Acquires Intelligent Medical Objects (IMO) for $1.5B+
  • Community Health Workers Slinging Free Heart Drugs Cut CV RisksCommunity Health Workers Slinging Free Heart Drugs Cut CV Risks
  • Roche Acquires Stratos Genomics to Expand Nanopore Sequencing TechnologyRoche Acquires Stratos Genomics to Expand Nanopore Sequencing Technology
  • How to Optimize and Enable Healthcare Marketing Resources With An Experienced Agency PartnerHow to Optimize and Enable Healthcare Marketing Resources With An Experienced Agency Partner
  • Sesen Bio and Carisma Therapeutics Announce Merger AgreementSesen Bio and Carisma Therapeutics Announce Merger Agreement
  • Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 VaccineHeat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications